Accéder au contenu
Merck

Liver functional metabolomics discloses an action of L-leucine against Streptococcus iniae infection in tilapias.

Fish & shellfish immunology (2015-05-11)
Yan-Mei Ma, Man-Jun Yang, Sanying Wang, Hui Li, Xuan-Xian Peng
RÉSUMÉ

Streptococcus iniae seriously affects the intensive farming of tilapias. Much work has been conducted on prevention and control of S. iniae infection, but little published information on the metabolic response is available in tilapias against the bacterial infection, and no metabolic modulation way may be adopted to control this disease. The present study used GC/MS based metabolomics to characterize the metabolic profiling of tilapias infected by a lethal dose (LD50) of S. iniae and determined two characteristic metabolomes separately responsible for the survival and dying fishes. A reversal changed metabolite, decreased and increased l-leucine in the dying and survival groups, respectively, was identified as a biomarker which featured the difference between the two metabolomes. More importantly, exogenous l-leucine could be used as a metabolic modulator to elevate survival ability of tilapias infected by S. iniae. These results indicate that tilapias mount metabolic strategies to deal with bacterial infection, which can be regulated by exogenous metabolites such as l-leucine. The present study establishes an alternative way, metabolic modulation, to cope with bacterial infections.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
L-Isoleucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
Adonitol, ≥99%
SAFC
L-Isoleucine
Sigma-Aldrich
L-Isoleucine, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
Adonitol, BioXtra, ≥99.0% (HPLC)
Sigma-Aldrich
L-Isoleucine, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
DL-Valine, ReagentPlus®, ≥99.0% (NT)
Sigma-Aldrich
L-Isoleucine, 99%, FCC, FG
Sigma-Aldrich
DL-Leucine, ≥99% (HPLC)
Sigma-Aldrich
DL-Valine, ≥97%